Abstract
A human/mouse chimeric Fab monoclonal antibody A7 (chFabA7) was covalently coupled to neocarzinostatin (NCS) by the SPDP method at various chFabA7:NCS substitution ratios. The antigen‐binding activity of the conjugate, examined by ELISA using fixed antigen‐positive colon cancer cells, was identical to that of the parent chFabA7 when one mole of NCS was conjugated, but was reduced with 2 or 3 moles of conjugated NCS. By means of a colony‐forming assay, the cytocidal effect of the conjugate on antigen‐positive cancer cells was found to be stronger than that of free NCS, whereas in antigen‐negative cancer cells it was similar to that of free NCS. This effect was attenuated by adding an excess amount of monoclonal antibody A7. These findings indicate that the conjugate has an antigen‐specific cytocidal action, and thus chFabA7‐NCS is a promising tool for targeting cancer chemotherapy.
Keywords: Mab A7, Chimeric antibody, Drug conjugate
Full Text
The Full Text of this article is available as a PDF (280.7 KB).
REFERENCES
- 1. ) Miller , R. A. and Levy , R.Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody . Lancet , ii , 226 – 230 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Herlyn , D. and Koplowski , H.IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells . Proc. Natl. Acad. Sci. USA , 79 , 4761 – 4765 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. ) Hurwitz , E.Specific and nonspecific macromolecule‐drug conjugates for the improvement of cancer chemotherapy . Biopolymer , 22 , 557 – 567 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Shawler , D. L. , Bartholomew , R. M. , Smith , L. M. and Dillman , R. O.Human immune response to multiple injection of murine monoclonal IgG . J. Immunol. , 135 , 1530 – 1535 ( 1985. ). [PubMed] [Google Scholar]
- 5. ) Tsukada , Y. , Ohkawa , K. and Hibi , N.Therapeutic effect of treatment with polyclonal or monoclonal antibodies to α‐fetoprotein that have been conjugated to daunomycin via dextran bridge: studies with an α‐fetoprotein producing rat hepatoma tumor model . Cancer Res. , 47 , 4293 – 4295 ( 1987. ). [PubMed] [Google Scholar]
- 6. ) Takahashi , T. , Yamaguchi , T. , Kitamura , K. , Suzuyama , H. , Honda , M. , Yokota , T. , Kotanagi , H. , Takahashi , M. and Hashimoto , Y.Clinical application of monoclonal antibody‐drug conjugates for immunotargeting chemotherapy of colorectal carcinoma . Cancer , 61 , 881 – 888 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Takahashi , T. , Yamaguchi , T. , Kitamura , K. , Noguchi , A. , Honda , M. and Otsuji , E.Missile therapy for colorectal and pancreatic cancer, clinical trials of monoclonal antibody‐drug conjugate A7‐NCS . Jpn. J. Cancer Chemother. , 17 , 1111 – 1119 ( 1990. ) ( in Japanese ). [PubMed] [Google Scholar]
- 8. ) Kotanagi , H. , Takahashi , T. , Masuko , T. , Hashimoto , Y. and Koyama , K.A monoclonal antibody against human colon cancers . Tohoku J. Exp. Med. , 148 , 353 – 360 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Kitamura , K. , Takahashi , T. , Yamaguchi , T. , Kitai , S. , Amagai , T. and Imanishi , J.Monoclonal antibody A7 tumor localization enhancement by its F(ab')2 fragments to colon carcinoma xenografts in nude mice . Jpn. J. Clin. Oncol. , 20 , 139 – 144 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Kitamura , K. , Takahashi , T. , Yamaguchi , T. , Yokota , T. , Noguchi , A. , Amagai , T. and Imanishi , J.Immunochemical characterization of the antigen recognized by the murine monoclonal antibody against human colorectal cancer . Tohoku J. Exp. Med. , 157 , 83 – 92 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Napier , M. A. , Holmquist , B. , Strydam , D. J. and Goldberg , I. H.Neocarzinostatin: spectral characterization and separation of non‐protein chromophpre . Biochem. Biophys. Res. Commun. , 89 , 635 – 642 ( 1979. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Koide , Y. , Ishii , F. , Hasuda , K. and Koyama , Y.Isolation of a protein component from neocarzinostatin (NCS) and their biological activities . J. Antibiot. , 33 , 342 – 346 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Kitamura , K. , Takahashi , T. , Noguchi , A. , Takashina , K. , Tsurumi , H. and Yamaguchi , T.Binding, internalization and the cytotoxicity of monoclonal antibody A7‐neocarzinostatin conjugates (A7‐NCS) in target cells . Tohoku J. Exp. Med. , 161 , 199 – 207 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Jung , G. , Kohnlein , W. and Luders , G.Biological activity of the antitumor protein neocarzinostatin coupled to a monoclonal antibody by N‐succinimidyl 3‐(2‐pyridyldithio)propionate . Biochem. Biophys. Res. Commun. , 101 , 599 – 606 ( 1981. ). [DOI] [PubMed] [Google Scholar]